Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dolby Laboratories (DLB) Shares Outstanding (Weighted Average) (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $95.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.16% year-over-year to $95.5 million, compared with a TTM value of $95.5 million through Dec 2025, changed 0.16%, and an annual FY2025 reading of $95.9 million, changed 0.34% over the prior year.
  • Shares Outstanding (Weighted Average) was $95.5 million for Q4 2025 at Dolby Laboratories, roughly flat from $95.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $101.3 million in Q2 2022 and bottomed at $95.4 million in Q4 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $97.5 million, with a median of $95.9 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Weighted Average) increased 0.62% in 2021, then decreased 5.41% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $101.2 million in 2021, then fell by 5.26% to $95.9 million in 2022, then dropped by 0.55% to $95.4 million in 2023, then grew by 0.25% to $95.6 million in 2024, then decreased by 0.16% to $95.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for DLB at $95.5 million in Q4 2025, $95.9 million in Q3 2025, and $95.9 million in Q2 2025.